The annual Highly Cited Researchers 2023 list from Clarivate (responsible for the Web of Science, considered the most relevant database for science) has just been published.
RUI L. REIS RECEBE IMPORTANTE PRÉMIO CIENTÍFICO ATRIBUÍDO PELA SOCIEDADE EUROPEIA DE BIOMATERIAIS (ESB)
O Diretor Fundador do Grupo 3B’s e atual Presidente do I3Bs da UMinho faz assim o hat-trick dos grandes prémios europeus de biomateriais, recebendo este prémio pela sua capacidade de Liderança, Mentoria e Orientação de jovens investigadores e pela sua contribuição para criar uma nova geração de cientistas.
As a result of the Protocol signed between Dom Manuel II Foundation (Portugal), represented by H.R.H. the Duke of Bragança, and the University of Minho and Municipality of Guimarães, it is announced the call for the attribution of the Award “Príncipe da Beira” Biomedical Sciences (3rd edition, year 2018/2019).
Rui L. Reis, Director of 3B's Research Group - Institute of Research in Biomaterials, Biomimetics and Biodegradables (I3Bs) of University of Minho, was distinguished on the 15th of November 2018 with the title of doctor honoris causa by the Universitatea POLITEHNICA din București (UPB), Romania. The ceremony took place at the Senate Hall of UPB, with the presence of several relevant invitees, including the Rector of UMinho, Prof. Rui Vieira de Castro.
PRÉMIO | O Prémio Príncipe da Beira Ciências Biomédicas, instituído pelo Município de Guimarães, pela Fundação D. Manuel II e pela Universidade do Minho, foi atribuído a Sílvia C. Araújo Vieira, pelo seu trabalho “Natural-based Hierarchical Platform for Islet Cell Transplantation and Vascularization".
Today we had the honour to receive at 3B's facilities D. Afonso, Príncipe das Beiras, D. Miguel de Bragança and also Sir Dr. Richard Hsieh, on the scope of the attribution of Prize Principe das Beiras em Ciências Biomédicas 2017, instituted between the Duque de Bragança, D. Duarte Pio de Bragança, through D. Manuel II Foundation, University of Minho and Guimarães Municipality.
A world expert in Tissue Engineering and Regenerative Medicine (TERM) has been awarded a prestigious international prize from the Institution of Engineering and Technology (IET). The prize fund will be used to create reliable breakthrough 3D engineered functional cancer disease models that can help predict the efficacy of cancer drugs, avoiding unnecessary animal testing and some clinical trials.